Creative Solutions to Pharma Market Access Issues in China

For life science companies building and executing a market access strategy in China, the question is rarely whether or not a big enough market exists to justify their efforts; rather, the most pressing question is what they will have to trade in order to open the market itself.  The question of what the exchange is [...]